Ardelyx to Receive $5M Milestone Payment as Japan Partner Initiates Phase 3
Ardelyx to Receive $5M Milestone Payment as Japan Partner Initiates Phase 3 Source: Streetwise Reports (4/15/21) Ardelyx Inc. shares traded 11% higher after Kyowa Kirin Co. Ltd., its collaborative partner in Japan, initiated four Phase 3 clinical trials of tenapanor for treatment of hyperphosphatemia. Biopharmaceutical company Ardelyx Inc. (ARDX:NASDAQ), which concentrates its efforts on the development of medicines to treat kidney and cardiorenal diseases, today announced that its collaboration partner in Japan, Kyowa Kirin Co., Ltd. (4151:TSE) "has initiated four Pha...